Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Vireo Growth's Business Segments
Vireo Growth's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Cannabis Segment
Total Revenue
$ 209
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Cannabis Segment84%
- Non Cannabis Segment16%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Cannabis Segment | $ 176 | 84% |
| Non Cannabis Segment | $ 34 | 16% |
Revenue by Product & Service Category - Q2 FY2026
- Retail73.6%
- Wholesale Product10.4%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Retail | $ 154 | 73.6% |
| Wholesale Product | $ 22 | 10.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Vireo Growth
Vireo Growth Inc. is a cannabis company operating in cultivation, manufacturing, wholesale, and retail sectors. The company has a presence in six U.S. states: Maryland, Minnesota, Missouri, Nevada, New York, and Utah. Vireo Growth cultivates and manufactures cannabis products in environmentally controlled greenhouses and other facilities. It distributes these products through its Green Goods™ and other Vireo Growth branded retail dispensaries, as well as third-party dispensaries licensed in its operating markets. As of March 17, 2026, Vireo Growth operates 36 retail dispensaries across these states and wholesales cannabis products through third-party companies in the same markets. Founded in 2014 as Minnesota Medical Solutions, LLC, the company received its first license in December 2014. Vireo Growth is publicly traded on the Canadian Securities Exchange under the symbol "VREO" and on the OTCQX under the symbol "VREOF". Its registered office is located in Vancouver, British Columbia, and its corporate office is in Minneapolis, Minnesota.
The Company operates in a single business segment focused on the cultivation, processing, and distribution of medical and adult-use cannabis products in various formats, along with related accessories. The Chief Executive Officer serves as the Chief Operating Decision Maker (CODM).
